SCHEMBL29066296

SCHEMBL29066296

[c]1cncc(C2=CCOCC2)c1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 1/20 0.39
PIK3CD O00329 7/20 0.36
PIK3CA P42336 7/20 0.36
PIK3CB P42338 7/20 0.36
PIK3CG P48736 6/20 0.36
CYP11B2 P19099 1/20 0.36
BACE1 P56817 2/20 0.35
KCNH2 Q12809 1/20 0.35
PIK3R1 P27986 4/20 0.32
SERPINA2 P20848 1/20 0.31
MTOR P42345 1/20 0.31
PRKDC P78527 1/20 0.31
ATR Q13535 1/20 0.31
ATRIP Q8WXE1 1/20 0.31
MAPK14 Q16539 1/20 0.30
HTR1D P28221 1/20 0.30
KDM4C Q9H3R0 1/20 0.30
CDC7 O00311 1/20 0.30
CDK2 P24941 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3723672 0.72 PSMB5 (0.37) CDK2
SCHEMBL20448631 0.71 PIK3CD (0.37) DYRK1APIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL2712585 0.70 CYP11B2 (0.46) DYRK1APIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL17686085 0.70 PIK3CA (0.47) DYRK1APIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL6291238 0.69
SCHEMBL18857842 0.66 MAPK14 (0.47) PIK3CDPIK3CAPIK3CBPIK3CGPIK3R1
SCHEMBL31704858 0.66 CYP11B2 (0.51) PIK3CDPIK3CAPIK3CBPIK3CGCYP11B2
SCHEMBL31706135 0.66 CYP11B2 (0.51) PIK3CDPIK3CAPIK3CBPIK3CGCYP11B2
SCHEMBL6095188 0.66
SCHEMBL18248008 0.64 PIK3CD (0.43) DYRK1APIK3CDPIK3CAPIK3CBPIK3CG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116724034-A 2, 3-dihydro-4H-benzo [ B ] [1,4] oxazin-4-yl (5- (phenyl) -pyridin-3-yl) methanone derivatives and similar compounds as CYP11A1 inhibitors for the treatment of prostate cancer 奥赖恩公司 2023-09-08 CN claimed
CN-116724034-A 2, 3-dihydro-4H-benzo [ B ] [1,4] oxazin-4-yl (5- (phenyl) -pyridin-3-yl) methanone derivatives and similar compounds as CYP11A1 inhibitors for the treatment of prostate cancer 奥赖恩公司 2023-09-08 CN disclosed